Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Ossium Health, Inc.
M.D. Anderson Cancer Center
Stanford University
Children's Hospital Medical Center, Cincinnati
M.D. Anderson Cancer Center
Thomas Jefferson University
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
University of Illinois at Chicago
Celyad Oncology SA